Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral minoxidil and dutasteride for male androgenetic alopecia
IRCT20240304061159N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of minoxidil and dutasteride in androgenetic alopecia (AGA) (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Changes in the number and density of hair. Started Apr 2024; status: completed.
02
Drugs
minoxidildutasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20240304061159N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240304061159N1.